Antioxidant N-acetylcysteine Inhibits Development Of Hypoxic Pulmonary Hypertension In Rats
Contact Person: Jan Herget (Jan.Herget@lfmotol.cuni.cz)
Chronic hypoxia results in pulmonary hypertension due to an increase in the pulmonary vascular resistance. Remodeling of the peripheral pulmonary arteries is a prominent feature. Vascular smooth muscle cells undergo proliferation and hypertrophy and encroach into the lumen of the alveolar vessels. The turnover of extracellular matrix proteins is increased and shifted towards the deposition of collagen and elastin fibres in the vascular walls (Reid, 1989). The structural reconstruction of the peripheral pulmonary arteries results from the injury to the vascular walls (Herget and Jezek, 1989). Evidence accumulates that the onset of hypoxic pulmonary hypertension is linked to the tissue injury of radical nature. Both nitric oxide (Hampl et al., 1993) and reactive oxygen species (Hoshikawa et al., 1995; Nakanishi et al., 1996) production in the lung is elevated in chronic hypoxia and may contribute to the vascular wall injury. Hoshikawa and co-workers (1995) showed that administration of n-acetylcysteine (NAC), an antioxidant, inhibits the pulmonary vascular oxidative damage and pulmonary hypertension in rats exposed to chronic hypoxia. The oxidant damage was assessed as the level of phosphatidylcholine hydroperoxide measured by chemiluminiscence - HPLC assay. An inhibition of hypoxic pulmonary hypertension was also seen after administration of another antioxidant, dimethylthiourea (Langleben et al., 1989), although the toxicity of the substance makes the interpretation of the mechanism questionable.
In the present study we studied the effects of NAC treatment on the lung hemodynamics in chronic hypoxia.
Materials and Methods
Sixteen rats were exposed to chronic hypoxia (FiO2 = 0.1) in an isobaric hypoxic chamber. Nine of these rats were treated with NAC (20 g/100 ml of drinking water) (group H+NAC). Remaining 7 rats obtained plain water (group H). Sixteen rats were kept in an atmospheric air; 10 obtained NAC in drinking water (group N+NAC), and 6 were normoxic controls (group N). Water consumption was measured every third day and did not differ between the groups.
Immediately after the end of the exposure to hypoxia, the pulmonary artery blood pressure was measured in closed chest rats anesthetized with thiopental (40 mg/kg b.w., i.p.). Then positive pressure ventilation with air was initiated and the chest was opened to measure cardiac output (Transonic Systems) and aortic blood pressure. Then the heart was excised, divided in parts, and weighed.
Rats exposed to chronic hypoxia gained body weight less than normoxic controls. The treatment with NAC did not influence the body weight. Systemic blood pressure and cardiac output were not affected by the sojourn in the hypoxic environment or by the NAC treatment (Table 1).
Body weight Aortic blood pressure Cardiac output [g] [torr] [ml/min] H 263 ± 21* 111 ± 6 28 ± 5 H+NAC 250 ± 17* 91 ± 5 23 ± 3 N 354 ± 20 107 ± 4 29 ± 4 N+NAC 305 ± 15 103 ± 5 24 ± 2
* = P < 0.001 compared with normoxic controls
Chronic hypoxia induced pulmonary hypertension, which was inhibited by the NAC treatment. The increase in pulmonary arterial mean blood pressure induced by chronic hypoxia was significantly (P < 0.001) smaller after NAC treatment (Fig. 1). NAC also prevented the increase in the relative weight of the right ventricle (Fig. 2).
Discussion and Conclusion
The main mechanism of the hypoxic pulmonary hypertension is the restriction of the pulmonary vascular bed by the structural remodelling of the peripheral pulmonary vasculature (Reid, 1989). The activation of mesenchymal cells in the vascular walls may be linked to the hypoxic tissue injury (Herget and Jezek, 1989). Production of oxygen radicals is increased during the hypoxic exposure (Nakanishi et al., 1995; Hoshikawa et al., 1995). Vascular changes similar to those seen in chronic hypoxia were noted after the exposure to chronic hyperoxia (Jones et al., 1983).
One possible source of oxygen radicals in chronic hypoxia are alveolar macrophages. Their numbers increase during the hypoxic exposure. In addition, alveolar macrophages are primed by hypoxia to produce more hydrogen peroxide (Tuhoy et al., 1993; Wilhelm et al., 1996).
Radical damage of collagen matrix proteins stimulates the proliferation of vascular smooth muscle "in vitro" (Bacakova et al., 1997). Interstitial collagenases are activated by peroxynitrite (reactive product of the superoxide and nitric oxide interaction) (Rajagopalan et al., 1996). The collagenolytic activity in peripheral pulmonary arteries is increased in chronic hypoxia (Novotna and Herget, 1998). Recently Galis and co-workers (1998) reported that NAC decreases the matrix degrading capacity of macrophages. Collagen breakdown products were shown to stimulate fibroproduction "in vitro" (Gardi et al., 1994) and "in vivo" (Gardi et al., 1990). Inhibition of collagenolytic activity prevents vascular remodelling after injury (Zempo et al., 1996).
We conclude that treatment with NAC inhibits the development of hypoxic pulmonary hypertension, probably due to its interaction with the matrix degrading mechanisms.
| Discussion Board | Previous Page | Your Poster Session |
|Herget, J.; Bíbová, J.; Hampl, V.; (1998). Antioxidant N-acetylcysteine Inhibits Development Of Hypoxic Pulmonary Hypertension In Rats. Presented at INABIS '98 - 5th Internet World Congress on Biomedical Sciences at McMaster University, Canada, Dec 7-16th. Available at URL http://www.mcmaster.ca/inabis98/oxidative/herget0589/index.html|
|© 1998 Author(s) Hold Copyright|